A longitudinal study of pulmonary function in Danish patients with systemic sclerosis

被引:38
作者
Jacobsen, S
Halberg, P
Ullman, S
HoierMadsen, M
Petersen, J
Mortensen, J
Wiik, A
机构
[1] Department of Rhematology, Hvidovre Hospital, DK-2650 Hvidovre
关键词
systemic sclerosis; lung function;
D O I
10.1007/BF02242456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the types, prevalence and development of respiratory abnormalities in patients with systemic sclerosis (SSc), and to correlate the results with clinical and serological findings. Methods: 176 patients with SSc observed longitudinally were retrospectively included in the study. The change per year of vital capacity (VC), forced expiratory volume in one second/vital capacity (FEV1/VC), diffusing capacity (DLco) and diffusing constant (Kco) of carbon monoxide from the first till the latest pulmonary function test were correlated to clinical and serological findings, including anti-centromere, anti-Scl-70, and antinucleolar antibodies. Results: An isolated reduction of DLco was seen in 47% and a restrictive ventilatory pattern in 25% of the patients. Restrictive ventilatory pattern correlated to pulmonary fibrosis, dyspnoea, a low prevalence (13%) of anticentromere antibodies and a high prevalence of anti-Scl-70 antibodies (36%). Progression of DLco reduction was related to long disease duration, presence of anticentromere antibodies and absence of treatment with penicillamine. Conclusion: Pulmonary involvement is common in patients with SSc. The occurrence of different serological abnormalities in patients with restrictive disease and in patients with progressive isolated reduction of DLco, suggests that the two types of pulmonary damage may have different pathogeneses rather than being different stages in the progression of pulmonary damage.
引用
收藏
页码:384 / 390
页数:7
相关论文
共 21 条
[1]   LUNG-FUNCTION ABNORMALITIES AND DECLINE OF SPIROMETRY IN SCLERODERMA - AN OVERRATED DANGER [J].
ABRAMSON, MJ ;
BARNETT, AJ ;
LITTLEJOHN, GO ;
SMITH, MM ;
HALL, S .
POSTGRADUATE MEDICAL JOURNAL, 1991, 67 (789) :632-637
[2]   LONG-TERM EVALUATION OF PENICILLAMINE OR CYCLOFENIL IN SYSTEMIC-SCLEROSIS - RESULTS FROM A 2-YEAR RANDOMIZED STUDY [J].
AKESSON, A ;
BLOMBULOW, B ;
SCHEJA, A ;
WOLLMER, P ;
VALIND, S ;
WOLLHEIM, FA .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1992, 21 (05) :238-244
[3]  
CORDERO EM, 1989, CHEST, V96, P9601
[4]  
DECLERCK LS, 1987, ARTHRITIS RHEUM, V30, P643
[5]   LONGITUDINAL CHANGES IN LUNG-FUNCTION AND RESPIRATORY SYMPTOMS IN PROGRESSIVE SYSTEMIC-SCLEROSIS - PROSPECTIVE-STUDY [J].
GREENWALD, GI ;
TASHKIN, DP ;
GONG, H ;
SIMMONS, M ;
DUANN, S ;
FURST, DE ;
CLEMENTS, P .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (01) :83-92
[6]  
GUTTADAURIA M, 1977, ARTHRITIS RHEUM, V20, P10719
[7]  
Humbel RL, 1993, MANUAL BIOL MARKERS, VA2, P1
[8]   SCLERODERMA HYPERTENSIVE RENAL CRISIS AND THE CHANGING PATTERN OF MORTALITY IN SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
LANGEVITZ, P ;
BUSKILA, D ;
LEE, P ;
HERCZ, G .
NEPHRON, 1991, 57 (01) :111-112
[9]  
MASI AT, 1988, J RHEUMATOL, V15, P894
[10]   PULMONARY-FUNCTION IN PROGRESSIVE SYSTEMIC-SCLEROSIS - COMPARISON OF CREST SYNDROME VARIANT WITH DIFFUSE SCLERODERMA [J].
OWENS, GR ;
FINO, GJ ;
HERBERT, DL ;
STEEN, VD ;
MEDSGER, TA ;
PENNOCK, BE ;
COTTRELL, JJ ;
RODNAN, GP ;
ROGERS, RM .
CHEST, 1983, 84 (05) :546-550